Cancer Management and Research
Volume 12, 2020 - Issue
Open access
109
Views
14
CrossRef citations to date
0
Altmetric
Original Research
Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy Predictor
Jian-De Cheng1 Department of Respiratory and Critical Care Medicine, The Shanxi Bethune Hospital, Taiyuan 030032, Shanxi, People’s Republic of China
, Li-Xun Chai2 Department of Thoracic Surgery, The Shanxi Bethune Hospital, Taiyuan 030032, Shanxi, People’s Republic of China
, Zhi-Ping Zhao1 Department of Respiratory and Critical Care Medicine, The Shanxi Bethune Hospital, Taiyuan 030032, Shanxi, People’s Republic of China
, Yan-Yan Hao1 Department of Respiratory and Critical Care Medicine, The Shanxi Bethune Hospital, Taiyuan 030032, Shanxi, People’s Republic of China
& Shuo Li3 Department of Respiratory and Critical Medicine, Tianjin Medical University General Hospital, Tianjin 300052, People’s Republic of ChinaCorrespondence[email protected]
Pages 5641-5650
|
Published online: 12 Jul 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.